Vimarsana
Biggest News Aggregation in the World

Colitis Congress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colitis Congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colitis Congress Today - Breaking & Trending Today

IBD: Saffron supplements may lower inflammation in ulcerative colitis - Vimarsana News

IBD: Saffron supplements may lower inflammation in ulcerative colitis

Adding saffron supplements to standard-of-care treatment for ulcerative colitis may help reduce inflammation and positively benefit patients, a new study indicates.

Palisade Bio Announces Positive Preclinical Data of Lead - Vimarsana News

Palisade Bio Announces Positive Preclinical Data of Lead

– Preclinical data demonstrated PALI-2108 to be safe and well tolerated – PALI-2108 is orally delivered and colon activated allowing for local activity...

Palisade Bio Shares Surge On Positive Preclinical Data For PALI-2108 - Vimarsana News

Palisade Bio Shares Surge On Positive Preclinical Data For PALI-2108

Palisade Bio, Inc. (PALI) saw a 88% increase in its stock on Monday following the announcement of positive preclinical data for its main asset, PALI-2108, at the Crohn's & Colitis Congress on January 25-27, 2024.

Sara Horst, MD, MPH: Telehealth's Impact on Patient Retention in IBD - Vimarsana News

Sara Horst, MD, MPH: Telehealth's Impact on Patient Retention in IBD

More than half of patients received return-IBD care via telehealth in the post-COVID period, and those with longer drive times were more likely to continue telehealth care.

New Study Shows SonarMD Drives 10X Reduction in Hospital Admissions and Emergency Visits Related to IBD - Vimarsana News

New Study Shows SonarMD Drives 10X Reduction in Hospital Admissions and Emergency Visits Related to IBD

/PRNewswire/ -- Technology-enabled patient engagement leads to 10 times fewer hospital admissions and emergency department (ED) visits among patients with...